Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Carolina Scagnolari and Massimo Clementi.
Carolina Scagnolari
Connection Strength
0.345
Massimo Clementi
  1. The synergistic interaction of interferon types I and II leads to marked reduction in severe acute respiratory syndrome-associated coronavirus replication and increase in the expression of mRNAs for interferon-induced proteins. Intervirology. 2007; 50(2):156-60.
    View in: PubMed
    Score: 0.087
  2. Increased sensitivity of SARS-coronavirus to a combination of human type I and type II interferons. Antivir Ther. 2004 Dec; 9(6):1003-11.
    View in: PubMed
    Score: 0.076
  3. Treatment of SARS with human interferons. Lancet. 2003 Oct 04; 362(9390):1158; author reply 1158-9.
    View in: PubMed
    Score: 0.070
  4. Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro. Pharmacol Res. 2021 01; 163:105255.
    View in: PubMed
    Score: 0.057
  5. Interferon-ß-1a Inhibition of Severe Acute Respiratory Syndrome-Coronavirus 2 In Vitro When Administered After Virus Infection. J Infect Dis. 2020 Aug 04; 222(5):722-725.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.